Erasca ERAS
NASDAQ ERAS
$14.39 +0.35 (+2.49%)
At close: Oct 23, 2026 · 4:00 PM EDT

Erasca (ERAS) Cash & Current Investments (2020 - 2026)

Updated

Erasca's Cash & Current Investments came in at $268.74 million for Q2 2026, down 10.6% from $300.66 million a year earlier but up 10.2% from the prior quarter.

Analysis

Erasca (ERAS) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Erasca's Cash & Current Investments was $276.08 million, down 7.5% from FY2024.

  • Cash & Current Investments has declined in each of the last three years, though with a five-year compound annual growth rate of 18.4% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $298.31 million in FY2024 (-4.5%), $312.35 million in FY2023 (-28.3%), $435.62 million in FY2022 (+5.1%) and $414.5 million in FY2021 (+249.2%).
  • The five-year range for quarterly Cash & Current Investments is $243.79 million (Q1 2026) to $486.6 million (Q3 2021).
  • Year-over-year, Cash & Current Investments has declined for seven consecutive quarters, with an average decline of 11.7% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2021 (growth of 684.6%), and the weakest in Q4 2023 (a decline of 28.3%).
  • Business Quant data shows ERAS's Cash & Current Investments at $243.79 million (Q1 2026), $276.08 million (Q4 2025) and $288.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Erasca 4.50 Bn 3.42 Bn - 268.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 268.74 Mn
Mar 31, 2026 243.79 Mn
Dec 31, 2025 276.08 Mn
Sep 30, 2025 288.40 Mn
Jun 30, 2025 300.66 Mn
Mar 31, 2025 304.59 Mn
Dec 31, 2024 298.31 Mn
Sep 30, 2024 318.91 Mn
Jun 30, 2024 408.41 Mn
Mar 31, 2024 393.76 Mn
Dec 31, 2023 312.35 Mn
Sep 30, 2023 296.67 Mn
Jun 30, 2023 317.25 Mn
Mar 31, 2023 389.74 Mn
Dec 31, 2022 435.62 Mn
Sep 30, 2022 355.93 Mn
Jun 30, 2022 292.73 Mn
Mar 31, 2022 392.53 Mn
Dec 31, 2021 414.50 Mn
Sep 30, 2021 486.60 Mn
API Access

Erasca Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ERAS&period=max&api_key=YOUR_API_KEY